-
DAC of The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals
Dac
EGAC00001002517
-
Early on-treatment changes in circulating tumor DNA fraction and response to enzalutamide or abiraterone in metastatic castration-resistant prostate cancer - Data Access Committee
Dac
EGAC00001003128
-
EGAD00000000048
Dataset
EGAD00000000048
-
MDS 5q- exome reads
Dataset
EGAD00001001058
-
WGS of Asian lung cancers
Dataset
EGAD00001001240
-
Transcriptome sequencing of Gingivo-buccal Cancer : ICGC-India Project_2020
Dataset
EGAD00001006003
-
BreastCancer_Miroarrays
Dataset
EGAD00010002251
-
Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths
Study
EGAS00001007402
-
DPY30 ChIP-seq
Dataset
EGAD00001001268
-
Targeted Validation Samples
Dataset
EGAD00001010934
-
LLD PhIPSeq
Dataset
EGAD00001010104
-
scATAC-seq of CD4+ T cells from blood and tumor of NSCLC patients
Study
EGAS50000000294
-
Integration of T Cell Repertoire, CyTOF, genotyping and symptomatology data reveals subphenotypic variability in COVID-19 Patients
Dataset
EGAD50000000840
-
Targeted long-read snIso-Seq of the human brain in neurodegenerative diseases
Dataset
EGAD50000000179
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis
Study
EGAS00001001788
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis -Part II
Study
EGAS00001003357
-
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (microarray)
Study
EGAS00001004755
-
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Study
EGAS00001006598
-
Molecular characterization of invasive lobular carcinoma
Dataset
EGAD00001000288
-
High-coverage whole-genome sequencing reveals structural variations in triple-negative breast cancer
Study
JGAS000095
-
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Study
phs002486
-
Detecting and Subtyping Lung Cancer Through Analysis of Circulating Tumor DNA
Study
phs003570
-
Immune and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 trials
Study
EGAS00001007563
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
CEHM
Study
EGAS00001002366